BEN TRE PHARMACEUTICAL |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13,450 VND | -0.37% |
|
+1.51% | +10.25% |
| Sales 2013 | 530B 20.68M 28.64M | Sales 2014 | 523B 20.41M 28.26M | Capitalization | 150B 5.87M 8.13M |
|---|---|---|---|---|---|
| Net income 2013 | 11.03B 430K 596K | Net income 2014 | 11.37B 443K 614K | EV / Sales 2013 | 0.31 x |
| Net Debt 2013 | 89.75B 3.5M 4.85M | Net Debt 2014 | 106B 4.15M 5.75M | EV / Sales 2014 | 0.49 x |
| P/E ratio 2013 |
6.9
x | P/E ratio 2014 |
13.2
x | Employees | - |
| Yield 2013 |
7.75% | Yield 2014 |
6.65% | Free-Float | 56.73% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.37% | ||
| 1 week | +1.51% | ||
| Current month | +6.75% | ||
| 1 month | +8.03% | ||
| 3 months | +9.35% | ||
| 6 months | +12.08% | ||
| Current year | +10.25% |
1 week
13 000.00
14 200.00
1 month
12 400.0014 200.00
Current year
11 500.0014 200.00
1 year
11 100.0014 700.00
3 years
8 681.8218 409.09
5 years
7 792.2118 409.09
10 years
7 792.2120 176.92
| Managers | Title | Age | Since |
|---|---|---|---|
Trieu Thu Pham
CEO | Chief Executive Officer | 44 | 14-12-04 |
Hanh Khac Nguyen
AUD | Comptroller/Controller/Auditor | 46 | - |
Tan Minh Vo
BRD | Director/Board Member | 54 | 13-06-18 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Le Phuoc Le
PRN | Corporate Officer/Principal | 60 | 88-12-31 |
| Sales & Marketing | 59 | 90-12-31 | |
Tan Minh Vo
BRD | Director/Board Member | 54 | 13-06-18 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-20 | 13,450 | -0.37% | 72,500 |
| 24-06-19 | 13,500 | +1.50% | 18,900 |
| 24-06-18 | 13,300 | -4.32% | 5,600 |
| 24-06-17 | 13,900 | -0.71% | 11,600 |
| 24-06-14 | 14,000 | +5.26% | 96,800 |
End-of-day quote Ho Chi Minh S.E., June 19, 2024
More quotes
Ben Tre Pharmaceutical JSC (Bepharco) is a Vietnam-based company engaged in the pharmaceutical industry. The Company is involved in the wholesaling, import and export of pharmaceutical products, materials, chemicals, packagings and biological products. It is also engaged in the manufacturing of pharmaceutical and medicinal products through its subsidiaries, as well as the retailing of drugs. In addition, the Company trades supplements, medical equipment, supplies and machinery. The Company also rents out space for commercial purposes.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| +10.25% | 8.66M | |
| +30.30% | 78.37B | |
| +3.54% | 25.35B | |
| +8.31% | 8.85B | |
| +13.45% | 8.85B | |
| -30.05% | 7.21B | |
| +17.70% | 5.33B | |
| +1.92% | 4.15B | |
| -7.07% | 3.47B | |
| +9.54% | 3.32B |
- Stock Market
- Equities
- DBT Stock
